When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?
Phillip Read, Annemiek de Ruiter(ViiV Healthcare (Spain)), Jane Anderson(Baylor College of Medicine), Sundhiya Mandalia(Chelsea and Westminster Hospital NHS Foundation Trust), David Hawkins(Chelsea and Westminster Hospital), Graham P. Taylor(NIHR Imperial Biomedical Research Centre), Yvonne Gilleece(University of Sussex), Palwasha Khan(Interactive Research and Development), Claire M. Naftalin(University Hospitals Sussex NHS Foundation Trust), U. Harrisson(Chelsea and Westminster Hospital NHS Foundation Trust)
Cited by 132
Related Papers
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|631
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
|AIDS|2014|597